These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 869670)

  • 21. Neuropsychopharmacology and the affective disorders. (Third of three parts).
    Schildkraut JJ
    N Engl J Med; 1969 Aug; 281(6):302-8 concl. PubMed ID: 4894568
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 25. Total and free plasma tryptophan levels in patients with affective disorders: effects of a peripheral decarboxylase inhibitor.
    Garfinkel PE; Warsh JJ; Stancer HC; Sibony D
    Arch Gen Psychiatry; 1976 Dec; 33(12):1462-6. PubMed ID: 999449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary metabolites of tryptophan, serotonin and norepinephrine in alcoholics.
    Akhter MI; Clark PM; Kricka LJ; Nicholson G
    J Stud Alcohol; 1978 May; 39(5):833-41. PubMed ID: 672222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CNS 3-methoxy-4-hydroxyphenylglycol: its peripheral assessment by isotopic dilution and theoretical significance.
    Tang SW; Stancer HC; Warsh JJ
    Brain Res Bull; 1978; 3(6):669-74. PubMed ID: 400926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome.
    Swann AC; Koslow SH; Katz MM; Maas JW; Javaid J; Secunda SK; Robins E
    Arch Gen Psychiatry; 1987 Apr; 44(4):345-54. PubMed ID: 2436590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of inhibition of serotonin synthesis on 5-hydroxyindoleacetic acid excretion, in healthy subjects.
    Alfieri AB; Cubeddu LX
    J Clin Pharmacol; 1994 Feb; 34(2):153-7. PubMed ID: 7512997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
    Steiner M; Radwan M; Elizur A; Blum I; Atsmon A; Davidson S
    Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects.
    Wehr TA; Muscettola G; Goodwin FK
    Arch Gen Psychiatry; 1980 Mar; 37(3):257-63. PubMed ID: 7362415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of urinary excretion of biogenic amine metabolites in epilepsy.
    Baliga L; Rao A; Raja A; Rao SN
    Acta Neurol Scand; 1983 Dec; 68(6):413-6. PubMed ID: 6198865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia.
    Paradisi R; Grossi G; Pintore A; Venturoli S; Porcu E; Capelli M; Flamigni C
    Acta Endocrinol (Copenh); 1991 Sep; 125(3):246-52. PubMed ID: 1950338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurochemical variables in delusional depression.
    Lykouras E; Markianos M; Malliaras D; Stefanis C
    Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic drugs and the metabolism of intracerebrally injected tryptamine, 5-hydroxytryptamine, and norepinephrine.
    Meek JL; Krall AR; Lipton MA
    J Neurochem; 1970 Dec; 17(12):1627-35. PubMed ID: 5492984
    [No Abstract]   [Full Text] [Related]  

  • 39. Simple high-performance liquid chromatographic method for the concurrent determination of the amine metabolites vanillylmandelic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, dihydroxyphenylacetic acid and homovanillic acid in urine using electrochemical detection.
    Joseph MH; Kadam BV; Risby D
    J Chromatogr; 1981 Dec; 226(2):361-8. PubMed ID: 6172439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metastatic cancer on platelet monoamine oxidase activity and serotonin metabolism.
    Feldman JM
    Cancer; 1979 Nov; 44(5):1751-6. PubMed ID: 498046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.